XPND Medical is moving to the
Biopôle life sciences campus in
XPND Medical SA, a consulting firm specializing in leading transformation projects in the Pharmaceutical and MedTech industries announces its relocation to the newly built Serine building on the Biopôle campus.
By moving to the Biopôle, XPND Medical integrates a dynamic network of now more than 110 life sciences companies and a community of over 2'400 talented members.
Lausanne, 1st June 2022
Daniel Cimon, CEO of XPND Medical, said: "We are very pleased to be moving to Biopôle, it's such a vibrant and dynamic community. I am certain that we will be inspired by innovative companies of all sizes and this integration will ensure that XPND Medical stays relevant for its clients and continues to expand. "